MiRxes: Tony Mok

Singapore-based cancer early detection company MiRxes has appointed medical oncologist Tony Mok to its scientific advisory board. Mok is the Li Shu Fan Medical Foundation endowed professor and chairman of the department of clinical oncology at the Chinese University of Hong Kong. Mok also cofounded the Lung Cancer Research Group, Chinese Thoracic Oncology Research Group, and Asia Thoracic Oncology Research Group, and has led multiple multi-national studies on personalized medicine in lung cancer, including the landmark Iressa Pan-Asia Study (IPASS), MiRxes said.